Rod Amir Rahimi, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Helminths | 1 | 2022 | 35 | 0.850 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2020 | 1837 | 0.760 |
Why?
|
| Immunologic Memory | 3 | 2020 | 1348 | 0.660 |
Why?
|
| Transforming Growth Factor beta | 5 | 2019 | 2006 | 0.580 |
Why?
|
| Respiratory Tract Infections | 1 | 2022 | 959 | 0.500 |
Why?
|
| Chemokines | 1 | 2018 | 954 | 0.460 |
Why?
|
| Lung Diseases | 1 | 2022 | 1884 | 0.410 |
Why?
|
| Immunity, Innate | 2 | 2022 | 2956 | 0.390 |
Why?
|
| Muscle Weakness | 1 | 2012 | 414 | 0.350 |
Why?
|
| Lampreys | 1 | 2008 | 31 | 0.330 |
Why?
|
| Physical Therapy Modalities | 1 | 2012 | 547 | 0.330 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 437 | 0.280 |
Why?
|
| Respiratory Insufficiency | 1 | 2012 | 1199 | 0.240 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2022 | 78 | 0.200 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2012 | 1348 | 0.200 |
Why?
|
| Intensive Care Units | 1 | 2012 | 3679 | 0.170 |
Why?
|
| Thorax | 1 | 2022 | 547 | 0.170 |
Why?
|
| Transcription Factors | 2 | 2009 | 12164 | 0.170 |
Why?
|
| Trans-Activators | 1 | 2009 | 2924 | 0.160 |
Why?
|
| Myofibroblasts | 2 | 2017 | 221 | 0.160 |
Why?
|
| Lung Injury | 1 | 2023 | 436 | 0.160 |
Why?
|
| Immunologic Surveillance | 1 | 2018 | 93 | 0.150 |
Why?
|
| Uncertainty | 1 | 2022 | 725 | 0.150 |
Why?
|
| Receptors, Cytokine | 1 | 2018 | 261 | 0.150 |
Why?
|
| Arteritis | 1 | 2019 | 159 | 0.150 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2008 | 3617 | 0.150 |
Why?
|
| Mammals | 1 | 2022 | 1135 | 0.140 |
Why?
|
| Chemokine CCL2 | 1 | 2019 | 617 | 0.140 |
Why?
|
| Lymphoid Tissue | 1 | 2018 | 455 | 0.140 |
Why?
|
| Lectins, C-Type | 1 | 2019 | 588 | 0.130 |
Why?
|
| Animals | 14 | 2023 | 168561 | 0.130 |
Why?
|
| Carrier Proteins | 1 | 2009 | 5019 | 0.130 |
Why?
|
| Receptors, Chemokine | 1 | 2018 | 669 | 0.120 |
Why?
|
| Fibroblasts | 3 | 2010 | 4143 | 0.120 |
Why?
|
| Hypersensitivity | 1 | 2023 | 1093 | 0.120 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2013 | 180 | 0.110 |
Why?
|
| Terminology as Topic | 1 | 2020 | 1548 | 0.110 |
Why?
|
| Aniline Compounds | 1 | 2017 | 983 | 0.110 |
Why?
|
| Dendritic Cells | 2 | 2019 | 2723 | 0.100 |
Why?
|
| Signal Transduction | 5 | 2019 | 23387 | 0.100 |
Why?
|
| Oncogene Proteins v-erbB | 1 | 2010 | 17 | 0.100 |
Why?
|
| Smad Proteins | 2 | 2010 | 162 | 0.100 |
Why?
|
| Particulate Matter | 1 | 2022 | 2523 | 0.090 |
Why?
|
| Apoptosis | 3 | 2017 | 9715 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 2986 | 0.090 |
Why?
|
| Cell Movement | 2 | 2019 | 5212 | 0.090 |
Why?
|
| Pulmonary Fibrosis | 1 | 2013 | 526 | 0.080 |
Why?
|
| Oncogene Protein v-akt | 1 | 2009 | 135 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2017 | 1932 | 0.080 |
Why?
|
| Gene Duplication | 1 | 2008 | 330 | 0.070 |
Why?
|
| Dogs | 2 | 2010 | 3910 | 0.070 |
Why?
|
| Biochemistry | 1 | 2007 | 113 | 0.070 |
Why?
|
| Neural Crest | 1 | 2008 | 275 | 0.070 |
Why?
|
| HeLa Cells | 2 | 2010 | 3127 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 4438 | 0.070 |
Why?
|
| Lung | 2 | 2022 | 9826 | 0.070 |
Why?
|
| Macrophages | 1 | 2019 | 5655 | 0.060 |
Why?
|
| Mesoderm | 1 | 2007 | 686 | 0.060 |
Why?
|
| Asthma | 1 | 2023 | 5955 | 0.060 |
Why?
|
| Body Patterning | 1 | 2008 | 626 | 0.060 |
Why?
|
| Lung Transplantation | 1 | 2012 | 1155 | 0.060 |
Why?
|
| Cystic Fibrosis | 1 | 2012 | 1178 | 0.060 |
Why?
|
| Lymphoma | 1 | 2012 | 1873 | 0.060 |
Why?
|
| Receptor, erbB-2 | 1 | 2013 | 2410 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2012 | 2414 | 0.060 |
Why?
|
| Epithelium | 1 | 2007 | 1680 | 0.050 |
Why?
|
| Methylmercury Compounds | 1 | 2003 | 96 | 0.050 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 1119 | 0.050 |
Why?
|
| Oncogenes | 1 | 2007 | 1263 | 0.050 |
Why?
|
| Sirolimus | 1 | 2009 | 1562 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2007 | 3701 | 0.050 |
Why?
|
| Phylogeny | 1 | 2008 | 2797 | 0.050 |
Why?
|
| Pneumonia | 1 | 2012 | 2117 | 0.050 |
Why?
|
| Ganglia, Spinal | 1 | 2003 | 517 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 10163 | 0.050 |
Why?
|
| Integrin alphaV | 1 | 2019 | 55 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2008 | 1937 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2009 | 2107 | 0.040 |
Why?
|
| Humans | 9 | 2023 | 742088 | 0.040 |
Why?
|
| Mice | 6 | 2023 | 81045 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 2938 | 0.040 |
Why?
|
| Autoantigens | 1 | 2023 | 891 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2023 | 1470 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 2842 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 3038 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2009 | 8436 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 21821 | 0.040 |
Why?
|
| Mitochondrial Membranes | 1 | 2017 | 175 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2009 | 3678 | 0.040 |
Why?
|
| Epidermis | 1 | 2019 | 527 | 0.040 |
Why?
|
| Dermis | 1 | 2017 | 207 | 0.030 |
Why?
|
| bcl-X Protein | 1 | 2017 | 411 | 0.030 |
Why?
|
| Candida albicans | 1 | 2019 | 394 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 1613 | 0.030 |
Why?
|
| Allergens | 1 | 2023 | 1314 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2023 | 1348 | 0.030 |
Why?
|
| Antioxidants | 1 | 2023 | 1659 | 0.030 |
Why?
|
| Vasculitis | 1 | 2019 | 521 | 0.030 |
Why?
|
| Inflammasomes | 1 | 2019 | 493 | 0.030 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 546 | 0.030 |
Why?
|
| Scleroderma, Systemic | 1 | 2017 | 313 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2019 | 2088 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 972 | 0.030 |
Why?
|
| Proteins | 1 | 2009 | 6096 | 0.030 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2017 | 541 | 0.030 |
Why?
|
| Bleomycin | 1 | 2013 | 499 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2013 | 276 | 0.030 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2013 | 381 | 0.030 |
Why?
|
| Inflammation | 2 | 2023 | 10578 | 0.020 |
Why?
|
| Aorta | 1 | 2019 | 2057 | 0.020 |
Why?
|
| Swiss 3T3 Cells | 1 | 2010 | 5 | 0.020 |
Why?
|
| Models, Biological | 1 | 2007 | 9581 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2013 | 625 | 0.020 |
Why?
|
| Fibrosis | 1 | 2017 | 2026 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 479 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2013 | 709 | 0.020 |
Why?
|
| Phenotype | 1 | 2007 | 16331 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 1740 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 400 | 0.020 |
Why?
|
| Monocytes | 1 | 2019 | 2593 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2013 | 1458 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2019 | 3465 | 0.020 |
Why?
|
| Benzamides | 1 | 2013 | 1378 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2019 | 3099 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 5872 | 0.020 |
Why?
|
| Cell Line | 2 | 2013 | 15994 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2010 | 808 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 9735 | 0.020 |
Why?
|
| Quinazolines | 1 | 2013 | 1355 | 0.020 |
Why?
|
| Neutrophils | 1 | 2019 | 3711 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2019 | 3455 | 0.020 |
Why?
|
| Skin | 1 | 2019 | 4353 | 0.020 |
Why?
|
| Mitochondria | 1 | 2017 | 3520 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 4211 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 9325 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3139 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2003 | 330 | 0.010 |
Why?
|
| Piperazines | 1 | 2013 | 2488 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2013 | 2933 | 0.010 |
Why?
|
| Neurites | 1 | 2003 | 380 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 2940 | 0.010 |
Why?
|
| Male | 2 | 2017 | 349538 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18006 | 0.010 |
Why?
|
| Adult | 1 | 2012 | 213712 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 5522 | 0.010 |
Why?
|
| Female | 2 | 2012 | 379592 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 8300 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 10943 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 7721 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2003 | 19223 | 0.000 |
Why?
|
| Rats | 1 | 2003 | 24265 | 0.000 |
Why?
|
| Pregnancy | 1 | 2003 | 29087 | 0.000 |
Why?
|